News
Rural Healthtech Pioneer CureBay Secures Rs 100 Cr for Nationwide AI Expansion
FundingOctober 25, 2026, 3:38 pm
CureBay secured Rs 100 crore in Pre-Series C funding, led by IvyCap Ventures. This capital powers nationwide expansion, strengthening its rural healthcare network. The healthtech innovator deploys advanced AI, IoT, and community workers. It transforms access to essential medical services across underserved regions. Its integrated model now spans seven states, serving millions. Plans include rapid growth and technological advancement, bringing quality care closer to home for countless families.
Bhubaneswar-based healthtech startup CureBay recently closed a significant funding round. It raised approximately Rs 100 crore in a Pre-Series C round. IvyCap Ventures led the investment. This capital injection propels CureBay's ambitious expansion plans across India. The company targets new states, including Andhra Pradesh.
The funding structure includes Rs 69 crore in equity. IvyCap Ventures and existing investors contributed this portion. Over Rs 30 crore arrived as debt. Trifecta Capital, Alteria Capital, and VentureSoul Partners provided the debt financing. This combined war chest fuels CureBay's mission. It aims to bridge critical healthcare gaps in rural communities.
CureBay’s strategy involves nationwide expansion. It will strengthen its existing healthcare delivery network. Critical investment also targets technology and AI capabilities. The company is developing an "Intelligence Layer." This AI-powered system will enhance patient screening. It will generate health insights and support clinical decision-making. The focus remains on making advanced healthcare accessible.
The company's leadership stresses a fundamental need. Rural India requires comprehensive systems, not just isolated applications. The capital infusion will scale this operating model. AI will perform heavy lifting. This ensures every family receives proper care. It delivers services close to their homes.
CureBay's model combines technology with strong on-ground execution. This unique approach garners significant investor interest. It promises to expand quality healthcare access. It targets underserved communities nationwide.
Founded in 2021, CureBay brings primary healthcare to smaller towns and villages. Priyadarshi Mohapatra, Shobhan Mahapatra, and Sanjay Swain co-founded the venture. Their vision is clear. Deliver essential medical services where they are needed most. Patients at CureBay clinics access doctor consultations, often via video. They receive medicines, diagnostic tests, and surgery facilitation. Annual health memberships further enhance patient care.
CureBay operates through a robust six-layer system. This integrated framework ensures comprehensive care delivery. It features IoT-enabled clinics. A vast network of "Swasthya Mitras," or community health workers, supports these clinics. A connected digital platform streamlines operations. AI-powered screening tools and risk alerts provide early detection. A 24/7 command center offers continuous support.
The company also offers CureBay Kavach. This is a subscription program. It encourages preventive care. Members receive consultations. They get support for medicines and diagnostics. Certain hospitalization costs are also covered. This affordable membership makes healthcare proactive.
CureBay's growth trajectory is impressive. In January 2023, it ran 17 e-clinics in Odisha districts. By May 2025, the network expanded to over 150 eClinics. These spanned Odisha and Chhattisgarh. Today, CureBay manages more than 250 tech-enabled clinics. These clinics operate across seven states. Key states include Odisha, Chhattisgarh, Jharkhand, and Bihar. Expansion into Andhra Pradesh is imminent.
The operational backbone is extensive. Over 1,800 Swasthya Mitras form the front line. They connect communities to care. More than 530 trained clinical staff ensure quality service. A network of 230 doctor partners provides expert consultations. Additionally, over 210 partner hospitals and laboratories support advanced care needs. This robust infrastructure enables widespread impact. CureBay has served over 17 lakh patients. It conducts more than 400 health camps monthly. These outreach programs are vital for community engagement.
The company's AI development is a core focus. CureBay invests heavily in Graphics Processing Units (GPUs). It trains its own AI models. These models screen patients efficiently. They assess health risks accurately. Current AI products target specific conditions. They identify skin conditions, analyze dental health, and screen hemoglobin levels. These tools enhance diagnostic capabilities. They improve patient outcomes.
CureBay also collaborates with government initiatives. It serves as a healthcare partner for Samriddhi Kendra. This initiative by the Department of Telecommunications utilizes BharatNet broadband. It establishes single-window rural service centers. The first Samriddhi Kendra launched in March 2026. Located in Umri village, Madhya Pradesh, it offers diverse services. Telemedicine consultations and diagnostics are available via a Health ATM. Education, farm advisory, and financial services also feature. CureBay's involvement ensures integrated health solutions.
CureBay’s funding history demonstrates consistent investor confidence. Early angel investors provided approximately $1.5 million. Elevar Equity led the Series A round in November 2022. Elevar further invested Rs 60 crore in a Series A1 extension. This January 2024 round totaled Rs 61.8 crore ($7.5 million). Elevar became CureBay's largest external shareholder.
May 2025 saw a $21 million Series B round. Bertelsmann India Investments led this round. Existing investor Elevar Equity participated. British International Investment, the UK's development finance institution, also joined. Reports indicated significant contributions. Bertelsmann committed about Rs 94 crore. British International Investment added Rs 34 crore. Elevar Equity contributed Rs 31 crore.
Before the latest Pre-Series C round, CureBay had already raised over $34.6 million. Investors included Bertelsmann India Investments, British International Investment, and Elevar Equity. This continuous financial backing underscores CureBay's potential. It solidifies its position as a transformative force in rural healthtech. The company continues its relentless pursuit. It aims to deliver comprehensive, accessible healthcare. It harnesses technology for a healthier India.
Bhubaneswar-based healthtech startup CureBay recently closed a significant funding round. It raised approximately Rs 100 crore in a Pre-Series C round. IvyCap Ventures led the investment. This capital injection propels CureBay's ambitious expansion plans across India. The company targets new states, including Andhra Pradesh.
The funding structure includes Rs 69 crore in equity. IvyCap Ventures and existing investors contributed this portion. Over Rs 30 crore arrived as debt. Trifecta Capital, Alteria Capital, and VentureSoul Partners provided the debt financing. This combined war chest fuels CureBay's mission. It aims to bridge critical healthcare gaps in rural communities.
CureBay’s strategy involves nationwide expansion. It will strengthen its existing healthcare delivery network. Critical investment also targets technology and AI capabilities. The company is developing an "Intelligence Layer." This AI-powered system will enhance patient screening. It will generate health insights and support clinical decision-making. The focus remains on making advanced healthcare accessible.
The company's leadership stresses a fundamental need. Rural India requires comprehensive systems, not just isolated applications. The capital infusion will scale this operating model. AI will perform heavy lifting. This ensures every family receives proper care. It delivers services close to their homes.
CureBay's model combines technology with strong on-ground execution. This unique approach garners significant investor interest. It promises to expand quality healthcare access. It targets underserved communities nationwide.
Founded in 2021, CureBay brings primary healthcare to smaller towns and villages. Priyadarshi Mohapatra, Shobhan Mahapatra, and Sanjay Swain co-founded the venture. Their vision is clear. Deliver essential medical services where they are needed most. Patients at CureBay clinics access doctor consultations, often via video. They receive medicines, diagnostic tests, and surgery facilitation. Annual health memberships further enhance patient care.
CureBay operates through a robust six-layer system. This integrated framework ensures comprehensive care delivery. It features IoT-enabled clinics. A vast network of "Swasthya Mitras," or community health workers, supports these clinics. A connected digital platform streamlines operations. AI-powered screening tools and risk alerts provide early detection. A 24/7 command center offers continuous support.
The company also offers CureBay Kavach. This is a subscription program. It encourages preventive care. Members receive consultations. They get support for medicines and diagnostics. Certain hospitalization costs are also covered. This affordable membership makes healthcare proactive.
CureBay's growth trajectory is impressive. In January 2023, it ran 17 e-clinics in Odisha districts. By May 2025, the network expanded to over 150 eClinics. These spanned Odisha and Chhattisgarh. Today, CureBay manages more than 250 tech-enabled clinics. These clinics operate across seven states. Key states include Odisha, Chhattisgarh, Jharkhand, and Bihar. Expansion into Andhra Pradesh is imminent.
The operational backbone is extensive. Over 1,800 Swasthya Mitras form the front line. They connect communities to care. More than 530 trained clinical staff ensure quality service. A network of 230 doctor partners provides expert consultations. Additionally, over 210 partner hospitals and laboratories support advanced care needs. This robust infrastructure enables widespread impact. CureBay has served over 17 lakh patients. It conducts more than 400 health camps monthly. These outreach programs are vital for community engagement.
The company's AI development is a core focus. CureBay invests heavily in Graphics Processing Units (GPUs). It trains its own AI models. These models screen patients efficiently. They assess health risks accurately. Current AI products target specific conditions. They identify skin conditions, analyze dental health, and screen hemoglobin levels. These tools enhance diagnostic capabilities. They improve patient outcomes.
CureBay also collaborates with government initiatives. It serves as a healthcare partner for Samriddhi Kendra. This initiative by the Department of Telecommunications utilizes BharatNet broadband. It establishes single-window rural service centers. The first Samriddhi Kendra launched in March 2026. Located in Umri village, Madhya Pradesh, it offers diverse services. Telemedicine consultations and diagnostics are available via a Health ATM. Education, farm advisory, and financial services also feature. CureBay's involvement ensures integrated health solutions.
CureBay’s funding history demonstrates consistent investor confidence. Early angel investors provided approximately $1.5 million. Elevar Equity led the Series A round in November 2022. Elevar further invested Rs 60 crore in a Series A1 extension. This January 2024 round totaled Rs 61.8 crore ($7.5 million). Elevar became CureBay's largest external shareholder.
May 2025 saw a $21 million Series B round. Bertelsmann India Investments led this round. Existing investor Elevar Equity participated. British International Investment, the UK's development finance institution, also joined. Reports indicated significant contributions. Bertelsmann committed about Rs 94 crore. British International Investment added Rs 34 crore. Elevar Equity contributed Rs 31 crore.
Before the latest Pre-Series C round, CureBay had already raised over $34.6 million. Investors included Bertelsmann India Investments, British International Investment, and Elevar Equity. This continuous financial backing underscores CureBay's potential. It solidifies its position as a transformative force in rural healthtech. The company continues its relentless pursuit. It aims to deliver comprehensive, accessible healthcare. It harnesses technology for a healthier India.